This paper, published in Diabetes Care, identifies key metabolites associated with incident type 2 diabetes (T2D).
This paper, published in Diabetes Care, identifies key metabolites associated with incident type 2 diabetes (T2D).
This panel provides precise quantitative measurements of >150 key biomarkers of inflammation and immune response.
See how our mass spectrometry-based workflows measure 3,600+ protein groups in CSF to probe the landscape of CNS disease.
Experts share best practices for leveraging multi-omics technologies and data to advance clinical research.
This multi-omics study, led by UPitt researchers, establishes causative linkages between key metabolites & PAH.
This paper, published in Science, establishes a genetic & metabolic paradigm linking key metabolites to PAH.
See how our label-free, DIA proteomics workflows measure 5,438 total protein groups, comprising ~70K peptides, in plasma.
See how the partnership complements Sapient’s mass spectrometry-based proteomics & multi-omics services.
This panel profiles 250+ biomarkers of inflammation & immune response, including low-abundance cytokines and chemokines.
This panel detects 120+ biomarkers of neurodegeneration, including neuro-specific & neuroinflammatory proteins.
